Elliott Bennett-Guerrero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elliott Bennett-Guerrero has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
Howard K. Song
3 shared publications- Daniel B. Mark
Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
2 shared publications Eric D. Peterson
2 shared publicationsHilary P. Grocott
2 shared publicationsJames S. Gammie
2 shared publicationsJyotsna Garg
2 shared publications
Latest Publications
- 16 April 2014
- Published by Wiley in Transfusion
- Vol. 54 (10) , 2544-2552
Randomized study of washing 40‐ to 42‐day‐stored red blood cells
Background: Pretransfusion washing of red blood cells (RBCs) stored for a longer duration may have theoretical advantages but few data exist to support this practice. In many hospital settings, use of a point‐of‐care cell washer could conceivably be used to quickly wash allogeneic RBCs before transfusion. The purpose of this preliminary study was to compare a point‐of‐care device with a common blood bank device for washing longer‐stored RBCs.Study Design and Methods: Forty RBC units stored for 40 to 42 days were randomized to washing with the COBE 2991 device (Terumo BCT; FDA‐cleared for washing stored RBCs) or the Cell Saver Elite (Haemonetics; FDA‐cleared point‐of‐care device for processing and washing fresh autologous shed whole blood). Supernatant and unit RBCs from unwashed (baseline) and washed blood were assayed for potassium, lactate, intracellular ATP, percentage of RBC recovery, cell‐free hemoglobin, RBC microparticles, and RBCs were examined for susceptibility to hemolysis by physical stress.Results: Both devices recovered a high percentage of RBCs and efficiently removed extracelluar potassium. Washing with the Elite resulted in significant increases in cell‐free Hb, percent hemolysis, and RBC microparticle production, whereas washing with the COBE 2991 did not (fold Δ = 2.1 vs. 1.0, 4.6 vs. 1.2, 2.0 vs. 1.1, respectively; p < 0.05). Hemolysis induced by physical stress was not altered by washing.Conclusion: Although point‐of‐care washing of longer‐stored RBCs is appealing, these preliminary data suggest that transfusion of washed, longer‐stored units could result in potentially greater exposure to plasma free Hb. More data are needed before this practice can be routinely recommended.
- 16 April 2014
- Published by Wiley in Transfusion
- Vol. 54 (10) , 2544-2552
Randomized study of washing 40‐ to 42‐day‐stored red blood cells
Background: Pretransfusion washing of red blood cells (RBCs) stored for a longer duration may have theoretical advantages but few data exist to support this practice. In many hospital settings, use of a point‐of‐care cell washer could conceivably be used to quickly wash allogeneic RBCs before transfusion. The purpose of this preliminary study was to compare a point‐of‐care device with a common blood bank device for washing longer‐stored RBCs.Study Design and Methods: Forty RBC units stored for 40 to 42 days were randomized to washing with the COBE 2991 device (Terumo BCT; FDA‐cleared for washing stored RBCs) or the Cell Saver Elite (Haemonetics; FDA‐cleared point‐of‐care device for processing and washing fresh autologous shed whole blood). Supernatant and unit RBCs from unwashed (baseline) and washed blood were assayed for potassium, lactate, intracellular ATP, percentage of RBC recovery, cell‐free hemoglobin, RBC microparticles, and RBCs were examined for susceptibility to hemolysis by physical stress.Results: Both devices recovered a high percentage of RBCs and efficiently removed extracelluar potassium. Washing with the Elite resulted in significant increases in cell‐free Hb, percent hemolysis, and RBC microparticle production, whereas washing with the COBE 2991 did not (fold Δ = 2.1 vs. 1.0, 4.6 vs. 1.2, 2.0 vs. 1.1, respectively; p < 0.05). Hemolysis induced by physical stress was not altered by washing.Conclusion: Although point‐of‐care washing of longer‐stored RBCs is appealing, these preliminary data suggest that transfusion of washed, longer‐stored units could result in potentially greater exposure to plasma free Hb. More data are needed before this practice can be routinely recommended.
- 1 February 2013
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 57 (1) , 18-19
Hemodynamic Impact of Dexmedetomidine Administration in 15,656 Noncardiac Surgical Cases
- 1 February 2013
- Published by Wolters Kluwer Health in Survey of Anesthesiology
- Vol. 57 (1) , 18-19
Hemodynamic Impact of Dexmedetomidine Administration in 15,656 Noncardiac Surgical Cases
- 11 January 2012
- Published by Wiley in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
- Vol. 79 (1) , 66-74
Impact of Red Blood Cell Transfusion on Global and Regional Measures of Oxygenation
Anemia is common in critically ill patients. Although the goal of transfusion of red blood cells is to increase oxygen‐carrying capacity, there are contradictory results about whether red blood cell transfusion to treat moderate anemia (eg, hemoglobin 7–10 g/dL) improves tissue oxygenation or changes outcomes. Whereas increasing levels of anemia eventually lead to a level of critical oxygen delivery, increased cardiac output and oxygen extraction are homeostatic mechanisms the body uses to prevent a state of dysoxia in the setting of diminished oxygen delivery due to anemia. In order for cardiac output to increase in the face of anemia, normovolemia must be maintained. Transfusion of red blood cells increases blood viscosity, which may actually decrease cardiac output (barring a state of hypovolemia prior to transfusion). Studies have generally shown that transfusion of red blood cells fails to increase oxygen uptake unless oxygen uptake/oxygen delivery dependency exists (eg, severe anemia or strenuous exercise). Recently, near‐infrared spectroscopy, which approximates the hemoglobin saturation of venous blood, has been used to investigate whether transfusion of red blood cells increases tissue oxygenation in regional tissue beds (eg, brain, peripheral skeletal muscle). These studies have generally shown increases in near‐infrared spectroscopy derived measurements of tissue oxygenation following transfusion. Studies evaluating the effect of transfusion on the microcirculation have shown that transfusion increases the functional capillary density. This article will review fundamental aspects of oxygen delivery and extraction, and the effects of red blood cell transfusion on tissue oxygenation as well as the microcirculation. Mt Sinai J Med 79:66–74, 2012. © 2012 Mount Sinai School of Medicine
- 11 January 2012
- Published by Wiley in Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
- Vol. 79 (1) , 66-74
Impact of Red Blood Cell Transfusion on Global and Regional Measures of Oxygenation
Anemia is common in critically ill patients. Although the goal of transfusion of red blood cells is to increase oxygen‐carrying capacity, there are contradictory results about whether red blood cell transfusion to treat moderate anemia (eg, hemoglobin 7–10 g/dL) improves tissue oxygenation or changes outcomes. Whereas increasing levels of anemia eventually lead to a level of critical oxygen delivery, increased cardiac output and oxygen extraction are homeostatic mechanisms the body uses to prevent a state of dysoxia in the setting of diminished oxygen delivery due to anemia. In order for cardiac output to increase in the face of anemia, normovolemia must be maintained. Transfusion of red blood cells increases blood viscosity, which may actually decrease cardiac output (barring a state of hypovolemia prior to transfusion). Studies have generally shown that transfusion of red blood cells fails to increase oxygen uptake unless oxygen uptake/oxygen delivery dependency exists (eg, severe anemia or strenuous exercise). Recently, near‐infrared spectroscopy, which approximates the hemoglobin saturation of venous blood, has been used to investigate whether transfusion of red blood cells increases tissue oxygenation in regional tissue beds (eg, brain, peripheral skeletal muscle). These studies have generally shown increases in near‐infrared spectroscopy derived measurements of tissue oxygenation following transfusion. Studies evaluating the effect of transfusion on the microcirculation have shown that transfusion increases the functional capillary density. This article will review fundamental aspects of oxygen delivery and extraction, and the effects of red blood cell transfusion on tissue oxygenation as well as the microcirculation. Mt Sinai J Med 79:66–74, 2012. © 2012 Mount Sinai School of Medicine
- Open Access
- 1 November 2011
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 6 (6) , 382-388
Pilot Study of Sternal Plating for Primary Closure of the Sternum in Cardiac Surgical Patients
Postoperative sternal wound complications are a significant problem in high-risk patients. In addition to closure with conventional wires, several systems involving rigid fixation with metal plates are currently available. The Rapid Sternal Closure System (Talon) is approved for stabilization and fixation of the anterior chest wall. Anecdotal evidence suggests that use of the Talon may result in improved postoperative recovery. Fifty-one cardiac surgical patients at higher risk for sternal wound complications were enrolled at two sites. Subjects were randomized to insertion of Talons (n = 28) or wires only (control, n = 23) for sternal closure. The primary endpoint was a comparison between study groups of the percent of baseline incentive spirometry volume through postoperative day 7. Secondary endpoints included other measures of quality of recovery, sternal wound infection, and nonunion. The percentage of preoperative incentive spirometry volume achieved was higher in the Talon arm (67% ± 32%) versus control (58% ± 24%); however, this was not statistically significant (P = 0.41). Use of the Talon was associated with decreased use of opiates (21.3 ± 11.8 vs 25.4 ± 21.6 mg, P = 0.44), increased ability to ambulate 1000 ft on postoperative day 5 (25% vs 13%, P = 0.28), and decreased duration of mechanical ventilation (median 0.5 vs 1.0 days, P = 0.24) and hospital length of stay (4.5 ± 3.2 vs 5.3 ± 4.0 days, P = 0.40). One superficial sternal wound infection was observed in each study arm. There were no cases of nonunion. In this pilot study, the primary endpoint was not statistically different between the treatment groups. Use of the Talon was associated with trends toward benefit in endpoints consistent with enhanced postoperative recovery, highlighting a need for additional data from larger randomized trials.
- 1 November 2011
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 6 (6) , 382-388
Open AccessPilot Study of Sternal Plating for Primary Closure of the Sternum in Cardiac Surgical Patients
Postoperative sternal wound complications are a significant problem in high-risk patients. In addition to closure with conventional wires, several systems involving rigid fixation with metal plates are currently available. The Rapid Sternal Closure System (Talon) is approved for stabilization and fixation of the anterior chest wall. Anecdotal evidence suggests that use of the Talon may result in improved postoperative recovery. Fifty-one cardiac surgical patients at higher risk for sternal wound complications were enrolled at two sites. Subjects were randomized to insertion of Talons (n = 28) or wires only (control, n = 23) for sternal closure. The primary endpoint was a comparison between study groups of the percent of baseline incentive spirometry volume through postoperative day 7. Secondary endpoints included other measures of quality of recovery, sternal wound infection, and nonunion. The percentage of preoperative incentive spirometry volume achieved was higher in the Talon arm (67% ± 32%) versus control (58% ± 24%); however, this was not statistically significant (P = 0.41). Use of the Talon was associated with decreased use of opiates (21.3 ± 11.8 vs 25.4 ± 21.6 mg, P = 0.44), increased ability to ambulate 1000 ft on postoperative day 5 (25% vs 13%, P = 0.28), and decreased duration of mechanical ventilation (median 0.5 vs 1.0 days, P = 0.24) and hospital length of stay (4.5 ± 3.2 vs 5.3 ± 4.0 days, P = 0.40). One superficial sternal wound infection was observed in each study arm. There were no cases of nonunion. In this pilot study, the primary endpoint was not statistically different between the treatment groups. Use of the Talon was associated with trends toward benefit in endpoints consistent with enhanced postoperative recovery, highlighting a need for additional data from larger randomized trials.
- 12 January 2011
- Published by American Medical Association (AMA)
- Vol. 305 (2) , 149-150
Blood Transfusion After Coronary Artery Bypass Graft Surgery—Reply
In Reply: We agree with Drs Dixon and Santamaria that differences in bleeding may have accounted for some of the variability we observed between centers in transfusion rates for red blood cells, platelets, and fresh frozen plasma. The Society of Thoracic Surgeons Adult Cardiac Surgery Database does not record estimated blood loss; therefore, this variable could not be analyzed. We minimized the effect of this potential confounder by selecting a very homogeneous analysis population, ie, isolated primary CABG with cardiopulmonary bypass. Because of multiple factors, such as capture of shed blood using cardiotomy suction and autologous blood salvage systems using centrifugation, an accurate estimation of blood loss is challenging in cardiac surgery with cardiopulmonary bypass.
- 12 January 2011
- Published by American Medical Association (AMA)
- Vol. 305 (2) , 149-150
Blood Transfusion After Coronary Artery Bypass Graft Surgery—Reply
In Reply: We agree with Drs Dixon and Santamaria that differences in bleeding may have accounted for some of the variability we observed between centers in transfusion rates for red blood cells, platelets, and fresh frozen plasma. The Society of Thoracic Surgeons Adult Cardiac Surgery Database does not record estimated blood loss; therefore, this variable could not be analyzed. We minimized the effect of this potential confounder by selecting a very homogeneous analysis population, ie, isolated primary CABG with cardiopulmonary bypass. Because of multiple factors, such as capture of shed blood using cardiotomy suction and autologous blood salvage systems using centrifugation, an accurate estimation of blood loss is challenging in cardiac surgery with cardiopulmonary bypass.
- 1 January 2011
- Published by Elsevier
Contributors
- Top Cited PapersOpen Access
- 13 October 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (14) , 1568-1575
Variation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery
Patients who undergo cardiac surgery receive a significant proportion of the 14 million units of allogeneic red blood cells (RBCs) transfused annually in the United States.1 Numerous observational studies in patients who underwent cardiac surgery have shown an association between RBC transfusion and adverse outcome, including morbidity, mortality, resource utilization, and quality of life.2-9 To date, no large randomized trials of transfusion thresholds have been conducted in cardiac surgery to our knowledge to address this issue.
- 13 October 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (14) , 1568-1575
Top Cited PapersOpen AccessVariation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery
Patients who undergo cardiac surgery receive a significant proportion of the 14 million units of allogeneic red blood cells (RBCs) transfused annually in the United States.1 Numerous observational studies in patients who underwent cardiac surgery have shown an association between RBC transfusion and adverse outcome, including morbidity, mortality, resource utilization, and quality of life.2-9 To date, no large randomized trials of transfusion thresholds have been conducted in cardiac surgery to our knowledge to address this issue.
- 9 September 2010
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (11) , 1038-1049
Gentamicin–Collagen Sponge for Infection Prophylaxis in Colorectal Surgery
Despite the routine use of prophylactic systemic antibiotics, surgical-site infection continues to be associated with significant morbidity and cost after colorectal surgery. The gentamicin–collagen sponge, an implantable topical antibiotic agent, is approved for surgical implantation in 54 countries. Since 1985, more than 1 million patients have been treated with the sponges. In a phase 3 trial, we randomly assigned 602 patients undergoing open or laparoscopically assisted colorectal surgery at 39 U.S. sites to undergo either the insertion of two gentamicin–collagen sponges above the fascia at the time of surgical closure (the sponge group) or no intervention (the control group). All patients received standard care, including prophylactic systemic antibiotics. The primary end point was surgical-site infection occurring within 60 days after surgery, as adjudicated by a clinical-events classification committee that was unaware of the study-group assignments. The incidence of surgical-site infection was higher in the sponge group (90 of 300 patients [30.0%]) than in the control group (63 of 302 patients [20.9%], P=0.01). Superficial surgical-site infection occurred in 20.3% of patients in the sponge group and 13.6% of patients in the control group (P=0.03), and deep surgical-site infection in 8.3% and 6.0% (P=0.26), respectively. Patients in the sponge group were more likely to visit an emergency room or surgeon's office owing to a wound-related sign or symptom (19.7%, vs. 11.0% in the control group; P=0.004) and to be rehospitalized for surgical-site infection (7.0% vs. 4.3%, P=0.15). The frequency of adverse events did not differ significantly between the two groups. Our large, multicenter trial shows that the gentamicin–collagen sponge is not effective at preventing surgical-site infection in patients who undergo colorectal surgery; paradoxically, it appears to result in significantly more surgical-site infections. (Funded by Innocoll Technologies; ClinicalTrials.gov number, NCT00600925.)
- 9 September 2010
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (11) , 1038-1049
Gentamicin–Collagen Sponge for Infection Prophylaxis in Colorectal Surgery
Despite the routine use of prophylactic systemic antibiotics, surgical-site infection continues to be associated with significant morbidity and cost after colorectal surgery. The gentamicin–collagen sponge, an implantable topical antibiotic agent, is approved for surgical implantation in 54 countries. Since 1985, more than 1 million patients have been treated with the sponges. In a phase 3 trial, we randomly assigned 602 patients undergoing open or laparoscopically assisted colorectal surgery at 39 U.S. sites to undergo either the insertion of two gentamicin–collagen sponges above the fascia at the time of surgical closure (the sponge group) or no intervention (the control group). All patients received standard care, including prophylactic systemic antibiotics. The primary end point was surgical-site infection occurring within 60 days after surgery, as adjudicated by a clinical-events classification committee that was unaware of the study-group assignments. The incidence of surgical-site infection was higher in the sponge group (90 of 300 patients [30.0%]) than in the control group (63 of 302 patients [20.9%], P=0.01). Superficial surgical-site infection occurred in 20.3% of patients in the sponge group and 13.6% of patients in the control group (P=0.03), and deep surgical-site infection in 8.3% and 6.0% (P=0.26), respectively. Patients in the sponge group were more likely to visit an emergency room or surgeon's office owing to a wound-related sign or symptom (19.7%, vs. 11.0% in the control group; P=0.004) and to be rehospitalized for surgical-site infection (7.0% vs. 4.3%, P=0.15). The frequency of adverse events did not differ significantly between the two groups. Our large, multicenter trial shows that the gentamicin–collagen sponge is not effective at preventing surgical-site infection in patients who undergo colorectal surgery; paradoxically, it appears to result in significantly more surgical-site infections. (Funded by Innocoll Technologies; ClinicalTrials.gov number, NCT00600925.)
- Open Access
- 18 August 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (7) , 755-762
Effect of an Implantable Gentamicin-Collagen Sponge on Sternal Wound Infections Following Cardiac SurgeryA Randomized Trial
Despite the use of prophylactic systemic antibiotics, postoperative sternal wound infection continues to be a serious problem after cardiac surgical procedures, especially in the increasing population of patients with diabetes and/or obesity. Sternal wound infection is associated with significant suffering, additional expense,1,2 lengthened hospital stay,3,4 and increased mortality. The gentamicin-collagen sponge was developed to prevent and/or treat wound infections by providing high local gentamicin concentrations without the high systemic concentrations associated with nephotoxicity.5 The sponge's collagen matrix is biodegradable. The gentamicin-collagen sponge (Innocoll Technologies Ltd, Roscommon, Ireland) received marketing approval in Germany in 1985, and is currently approved for use in another 53 countries. To date, more than 2 million sponges have been used to treat more than 1 million patients outside the United States across a broad range of clinical indications (Innocoll Technologies Ltd, unpublished data, October 2007).
- 18 August 2010
- Published by American Medical Association (AMA) in JAMA
- Vol. 304 (7) , 755-762
Open AccessEffect of an Implantable Gentamicin-Collagen Sponge on Sternal Wound Infections Following Cardiac SurgeryA Randomized Trial
Despite the use of prophylactic systemic antibiotics, postoperative sternal wound infection continues to be a serious problem after cardiac surgical procedures, especially in the increasing population of patients with diabetes and/or obesity. Sternal wound infection is associated with significant suffering, additional expense,1,2 lengthened hospital stay,3,4 and increased mortality. The gentamicin-collagen sponge was developed to prevent and/or treat wound infections by providing high local gentamicin concentrations without the high systemic concentrations associated with nephotoxicity.5 The sponge's collagen matrix is biodegradable. The gentamicin-collagen sponge (Innocoll Technologies Ltd, Roscommon, Ireland) received marketing approval in Germany in 1985, and is currently approved for use in another 53 countries. To date, more than 2 million sponges have been used to treat more than 1 million patients outside the United States across a broad range of clinical indications (Innocoll Technologies Ltd, unpublished data, October 2007).